Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
16 studies found for:    Ataxia Telangiectasia
Show Display Options
RSS Create an RSS feed from your search for:
Ataxia Telangiectasia
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Enrolling by invitation Susceptibility to Infections in Ataxia Telangiectasia
Conditions: Ataxia Telangiectasia;   Infections;   Immunodeficiency;   Lung Disease
Interventions: Procedure: Blood collection;   Procedure: Lung function measurement;   Behavioral: Symptom diary
2 Completed Body Composition and Hormonal Status in Ataxia Telangiectasia
Condition: Ataxia Telangiectasia
Interventions: Procedure: bioelectrical impedance analysis;   Procedure: blood draw
3 Completed Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT)
Condition: Ataxia Telangiectasia (AT)
Intervention: Drug: Conjugated pneumococcal vaccine (Prevenar)
4 Unknown  Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)
Conditions: Ataxia Telangiectasia;   Growth Failure
Intervention: Drug: Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate
5 Unknown  Immunogenicity of Pneumococcal Vaccines in Ataxia-telangiectasia Patients
Condition: Ataxia Telangiectasia
Interventions: Biological: Prevenar® (7-valent pneumococcal conjugate vaccine);   Biological: Pneumovax® (pneumococcal polysaccharide vaccine)
6 Recruiting Oxidative Stress, Low Grade Inflammation, Tissue Breakdown and Biomarkers in Cerebrospinal Fluid of A-T
Condition: Ataxia Telangiectasia
Intervention: Procedure: Lumbar puncture
7 Not yet recruiting Cell-Based Approaches For Modeling and Treating Ataxia-Telangiectasia
Condition: Ataxia-Telangiectasia (A-T)
Interventions: Other: with gene correction;   Other: without gene correction
8 Completed Study for Treatment of Cancer in Children With Ataxia-telangiectasia
Condition: Ataxia-Telangiectasia
Interventions: Drug: vinblastine, vincristine, prednisone, daunorubicin;   Drug: doxorubicin, methotrexate, cyclophosphamide, L-asparaginase;   Drug: etoposide, cytarabine, mercaptopurine;   Drug: dexamethasone, procarbazine;   Procedure: chemotherapy, intrathecal chemotherapy, steroid therapy
9 Unknown  Baclofen Treatment of Ataxia Telangiectasia
Condition: Ataxia Telangiectasia
Interventions: Drug: Baclofen;   Drug: Placebo
10 Unknown  The Validity of Forced Expiratory Maneuvers in Ataxia Telangiectasia Studied Longitudinally
Condition: Ataxia Telangiectasia
Intervention:
11 Completed Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia
Conditions: Ataxia;   Chorea;   Dystonia;   Parkinsonism;   Fatigue
Intervention: Drug: amantadine sulphate
12 Completed International Ataxia Rating Scale in Younger Patients
Condition: Ataxia Telangiectasia
Intervention:
13 Not yet recruiting Pancreatic Cancer Screening of High-Risk Residents of Arkansas
Conditions: Pancreatic Neoplasms;   Peutz-Jegher's Syndrome;   BRCA1 Gene Mutation;   BRCA2 Gene Mutation;   Ataxia Telangiectasia;   Familial Atypical Mole-Malignant Melanoma Syndrome;   Colorectal Neoplasms, Hereditary Nonpolyposis;   Hereditary Pancreatitis
Intervention: Other: Pancreatic Cancer Screening
14 Active, not recruiting Development of iPS From Donated Somatic Cells of Patients With Neurological Diseases
Condition: Neurodegenerative Disorders
Intervention:
15 Completed Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant
Condition: Cancer
Intervention: Drug: caspofungin acetate
16 Withdrawn A Study of MK-4827 for the Treatment of Mantle Cell Lymphoma (MK-4827-002)
Conditions: Lymphoma;   Mantle-Cell
Intervention: Drug: MK-4827

Indicates status has not been verified in more than two years